Taylor Barca

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models

Z. An, S. Abbot, Swapna Panuganti, 2022, Clinical & translational immunology.

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

Z. An, M. Tabrizizad, A. Lucas, 2021, Journal for ImmunoTherapy of Cancer.

A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential

M. Beltramello, A. Cavalli, E. Harris, 2017, Cell.

198 Innate-enhanced chimeric adaptors (CAd): A newly-described approach for augmenting potency of γδ T cell immunotherapy

M. Tabrizizad, Gauri Lamture, B. Aftab, 2022, Regular and Young Investigator Award Abstracts.

119 ADI-002: an IL-15 armored allogeneic ‘off-the-shelf’ Vδ1 gamma delta CAR T cell therapy for solid tumors targeting glypican-3 (GPC3)

A. Lucas, Z. An, M. Tabrizizad, 2021, Journal for ImmunoTherapy of Cancer.